Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
The new Bioprocessing Collaboration Center (BCC) in St. Louis, Missouri, uniquely positions Thermo Fisher to bring together industry-leading expertise in single-use technologies and biologics product development and manufacturing to deliver unmatched value to our customers.
The facility is adjacent to our biologics manufacturing facility, which recently doubled production capacity with a $50M expansion. The combined expertise from our bioproduction and pharma services businesses will accelerate innovation and enhance productivity for biopharma customers, enabling them to meet the growing need for more flexible, scalable biologics development and manufacturing solutions.
The team will work together to develop innovative bioprocessing technologies, products and services that will enhance bioprocess workflows and enable our customers to take their products to market faster and with greater efficiency. The BCC will bring together the company’s leadership in GMP biologics manufacturing with its deep expertise in bioprocessing technologies including bioreactors, cell culture media, chromatography, analytical tools, among others. This collaboration will deliver new single-use bioprocessing technologies as well as drive critical process, data management and quality improvements that enable scale-up solutions for biopharma customers.
Read the BCC Press Release.